MedPath

Part 2 on the Study Prevalence of SARS -Cov2 Carriage in Asymptomatic and Mildly-symptomatic Children (COVILLE2) (WHO)

Withdrawn
Conditions
COVID19
Interventions
Diagnostic Test: RT-PCR SARS-Cov2
Diagnostic Test: Sars-Cov2 serology
Registration Number
NCT04416893
Lead Sponsor
Centre Hospitalier Intercommunal Creteil
Brief Summary

France and in particular the paris area was one of the countries most affected by the pandemic Covid19.

School closures and a generalized lockdown of the population were instituted in France from 17 March 2020 to 10 May 2020. Schools and nurseries have reopened partially since 11 May 2020. From 2 June, this reopening is more widespread. By combining the search for SARS-Cov2 viruses by PCR and micro-method serology we will be able to evaluate both the infection at a given time and also older contact with SARS-CoV2.

The temporal knowledge of the prevalence of SARS-Cov2 carriage and the serological status (IgM and IgG) after return to the community are crucial information to evaluate the speed of spread of the virus in children. This is the objective of COVILLE2, phase 2 of the COVILLE study.

Detailed Description

Not available

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • Birth to 15 years old
  • taking over the community (kindergarten, school, college, holiday centre, etc.) for at least 1 week
Exclusion Criteria
  • refusal to participate

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Children under 15 years of age in a communitySars-Cov2 serologyChildren under 15 years of age in a community : kindergarten, school, college, holiday center, etc.
Children under 15 years of age in a communityRT-PCR SARS-Cov2Children under 15 years of age in a community : kindergarten, school, college, holiday center, etc.
Primary Outcome Measures
NameTimeMethod
Proportion of asymptomatic children or children with mild respiratory symptomsAt inclusion

Proportion of asymptomatic children or children with mild respiratory symptoms (mildly-symptomatic children) with a positive SARS-Cov2 Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) on rhino pharyngeal swab or/and IgM/IgG positive serology in Paris area

Secondary Outcome Measures
NameTimeMethod
Cov2-SARS cases by ageAt inclusion
Viral loadAt inclusion

The viral load of children with SARS-Cov2 positive Reverse Transcriptase Polymerase Chain Reaction depending on the symptoms and the age of the patients

Cov2-SARS cases by symptomsAt inclusion
Presence of anti-SARS-CoV-2 antibodies (IgM and IgG) by the rapid serological testAt inclusion
© Copyright 2025. All Rights Reserved by MedPath